Roth CL, Perez FA, Whitlock KB, Elfers C, et al. A phase 3 randomized clinical trial using a once-weekly glucagon-like peptide-1
receptor agonist in adolescents and young adults with hypothalamic obesity. Diabetes Obes Metab 2021;23:363-373.
PMID: 33026160